Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| STOCK BUILDING SUPPLY HOLDINGS, INC. | 6,413,983 | reported | 12 Dec 2016 | tx 1−1,500,000 |
| ARKO Corp. | 116,833 | reported | 01 Jan 2026 | tx 14+116,833 |
| Chelsea Therapeutics International, Ltd. | 39,725 | reported | 22 Mar 2007 | tx 3+202,941 |
| ARKO Petroleum Corp. | 20,000 | reported | 13 Feb 2026 | tx 1+20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Feb 2026 | PURCHASE | ARKO Petroleum Corp. | 20,000 | 18.00 USD | first after silence |
| 01 Jan 2026 | GRANT_AWARD | ARKO Corp. | 6,607 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | ARKO Corp. | 5,482 | 0.00 USD | deriv |
| 01 Jul 2025 | GRANT_AWARD | ARKO Corp. | 5,422 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | ARKO Corp. | 28,473 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | ARKO Corp. | 6,203 | 0.00 USD | deriv |
| 01 Jan 2025 | GRANT_AWARD | ARKO Corp. | 3,793 | 0.00 USD | deriv |
| 01 Oct 2024 | GRANT_AWARD | ARKO Corp. | 3,623 | 0.00 USD | deriv |
| 01 Jul 2024 | GRANT_AWARD | ARKO Corp. | 4,332 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | ARKO Corp. | 20,226 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | ARKO Corp. | 4,332 | 0.00 USD | deriv |
| 01 Jan 2024 | GRANT_AWARD | ARKO Corp. | 9,090 | 0.00 USD | deriv |
| 01 Oct 2023 | GRANT_AWARD | ARKO Corp. | 3,496 | 0.00 USD | deriv |
| 01 Jul 2023 | GRANT_AWARD | ARKO Corp. | 3,144 | 0.00 USD | deriv |
| 20 Jun 2023 | GRANT_AWARD | ARKO Corp. | 12,610 | 0.00 USD | deriv |
| 12 Dec 2016 | SALE | STOCK BUILDING SUPPLY HOLDINGS, INC. | 1,500,000 | 19.22 USD | |
| 22 Mar 2007 | PURCHASE | Chelsea Therapeutics International, Ltd. | 132,416 | 4.72 USD | |
| 22 Mar 2007 | PURCHASE | Chelsea Therapeutics International, Ltd. | 39,725 | 0.00 USD | deriv |
| 22 Feb 2007 | PURCHASE | Chelsea Therapeutics International, Ltd. | 30,800 | 6.12 USD |
1 purchase reported after at least 12 months of silence — most recent on 13 Feb 2026.